Sort
48,018 grants matching “immunotherapy”
Research Training in Hematology
$437,427John Patrick Sheehan · University Of Wisconsin-Madison · T32 · FY2021 · HL
Bacterial Quorum Sensing as Target for Anti-Infective Immunotherapy
$437,385Bin Zhou · Scripps Research Institute, The · R01 · FY2013 · AI
ALDH Inhibition as Modulator of Tumor Immunobiology
$437,359Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2021 · CA
Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas
$437,284Jianguo Tao · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Combination of Anti-CD3 and Ag-Specific Immunotherapy
$437,250Columbia University Health Sciences · R21 · FY2005 · DK
The role of transcription elongation defects in immunotherapy resistance in cancers
$437,206Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
The role of transcription elongation defects in immunotherapy resistance in cancers
$437,202Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
B7-H1/PD-1 modulation in cancer therapy
$437,199Drew M. Pardoll · Johns Hopkins University · R01 · FY2013 · CA
Adoptive Immunotherapy for Multiple Myeloma Using Educated T Cells
$437,181Donald W. Kufe · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Targeting ER+ Breast Cancer Through Induced Viral Mimicry
$437,141Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA
Targeting the FBXO44/SUV39H1 Pathway in Cancer
$437,141Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA
Complement and Pathogenic Mechanisms of AMD
$437,134Catherine Bowes Rickman · Duke University · R01 · FY2014 · EY
Fast Targeted Spectroscopic Imaging for Brain Tumor Imaging at 3T and 7T
$437,080Jullie W Pan · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · EB
Immunobiology of Myeloid and Lymphoid Cells
$437,058William R Green · Dartmouth College · T32 · FY2009 · AI
Uncovering the heterogenous role of senescence in prostate immune suppression and tumorigenesis
$436,965Marcus A. Ruscetti · Univ Of Massachusetts Med Sch Worcester · R37 · FY2025 · CA
WEE1 inhibition and tumor immunity
$436,922Bin Zhang · Northwestern University At Chicago · R01 · FY2019 · CA
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
$436,886Amaia Lujambio · Icahn School Of Medicine At Mount Sinai · R37 · FY2020 · CA
Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies
$436,841Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Role of necroptosis in colorectal cancer therapy
$436,808Lin Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$436,798Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2023 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$436,798Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2022 · CA
Immunotherapy for acute lung injury secondary to influenza
$436,772Paul R Knight · State University Of New York At Buffalo · R01 · FY2020 · HL
Immunotherapy for acute lung injury secondary to influenza
$436,772Paul R Knight · State University Of New York At Buffalo · R01 · FY2021 · HL
Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells
$436,772Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Immunotherapy for acute lung injury secondary to influenza
$436,772Paul R Knight · State University Of New York At Buffalo · R01 · FY2022 · HL